Use of Entresto Sacubitril/Valsartan for the Treatment of Peripheral Arterial Disease

NCT02636283 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Recruitment

Conditions

Peripheral Arterial Disease

Interventions

DRUG: Entresto
DRUG: Placebo group

Sponsor

University of Minnesota

Collaborators

[object Object]